News

Minerva Neurosciences to Present at Jefferies 2017 Healthcare Conference on June 6, 2017

WALTHAM, Mass., May 30, 2017 (GLOBE NEWSWIRE) — Minerva Neurosciences, Inc. (NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system (CNS) disorders, today announced that it will present at the Jefferies 2017 Global Healthcare Conference on June 6, 2017 at 11:00 a.m. Eastern Time.

2017-06-20T12:26:08+00:00